by Peter Bacchetti, Steven G. Deeks, and Joseph M. McCune

Slides:



Advertisements
Similar presentations
Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? by Stephen F. Kingsmore, and Carol J. Saunders Sci Transl Med Volume.
Advertisements

The Bayh-Dole Act Turns 30 by Vicki Loise, and Ashley J. Stevens Sci Transl Med Volume 2(52):52cm27-52cm27 October 6, 2010 Published by AAAS.
Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.
Fig. 6 Transmissibility of adiposity from humanized mice to germ-free recipients. Transmissibility of adiposity from humanized mice to germ-free recipients.
Fig. 7 Correlation of NHP and human ISGs.
Fig. 1 Movement percepts for all participants.
Fig. 4. Peanut-specific TH2A cells are specifically targeted during immunotherapy. Peanut-specific TH2A cells are specifically targeted during immunotherapy.
Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 4 Labeling of Msmeg with DMN-Tre is fast and specific and depends on Ag85A function. Labeling of Msmeg with DMN-Tre is fast and specific and depends.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Filipin staining of marginal gyrus of cerebral cortex in NPC cats
Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 7 Bacterial dependency networks in IgA deficiency and HDs.
Fig. 6. TIV-09, but not MIV-09, induces an IFN signature in the blood of vaccinated individuals at day 1. TIV-09, but not MIV-09, induces an IFN signature.
Fig. 3 ROC curves of mCCNA1 and mVIM assayed in esophageal cytology brushings from control normal-appearing GE junctions versus BE and EAC cases. ROC curves.
Fig. 3 Projected gains in MCP.
Fig. 2 Preserved long-term functionality of the TEHVs over 1-year follow-up as assessed by ICE and cardiac MRI flow measurements. Preserved long-term functionality.
In vivo release of doxycycline hyclate from the GRS in a swine model
Fig. 4 Deorphanization of quinine and mefloquine protein targets.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 1. Value proposition. Value proposition.Summarized are the valuation estimates (log scale), from panel members (selected by A.W.L.) for the NCATS.
Fig. 1 Experimental apparatus used to train and test free-flying bees on their capacity to learn addition and subtraction. Experimental apparatus used.
Fig. 2 TRXSS data. TRXSS data. TRXSS data covering delay times from 10 ns to 10 ms for wild-type DmCry (A), for the DmCry(H378A) mutant (B), and for XlPho.
Fig. 2 LYM attractor metagene.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Colonization in tumor models and different modes of administration
Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.
Fig. 4 Device accuracy results (n = 32 users).
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
The microchip-based drug delivery device and overview of study design
Fig. 5. Octet BLI competition assay using D25 and motavizumab.
Fig. 4 EUV TG signal from Si.
Fig. 1 From conventional cuff-based blood pressure measurement to cuff-less BP monitoring using a smartphone. From conventional cuff-based blood pressure.
Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.
AEGIS autonomous targeting process.
Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.
Fig. 3 Local Maraba treatment of TNBC tumors provides long-term systemic protection. Local Maraba treatment of TNBC tumors provides long-term systemic.
A Role for Science Investments in Advancing Newborn Health
Fig. 1 Most models of biological responses to climate change omit important biological mechanisms. Most models of biological responses to climate change.
Single-cell analyses to tailor treatments
PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models
Fig. 1 Crohn’s disease association within the LRRK2 locus.
Fig. 2 Effect of CSF sTREM2– and CSF sTREM2–to–p-tau181 ratio on changes in cognition. Effect of CSF sTREM2– and CSF sTREM2–to–p-tau181 ratio on changes.
A “datathon” model to support cross-disciplinary collaboration
Fig. 8. Purkinje cell quantification and hearing threshold in NPC cats administered IC HPβCD. Purkinje cell quantification and hearing threshold in NPC.
Fig. 5. Vascularization of human liver seed grafts.
Fig. 2. Overexpression of miR cluster in the developing heart results in increased cardiomyocyte proliferation and cardiomegaly. Overexpression.
Fig. 3 FTIR spectra of plastic standards and sediment samples.
Delineating cancer evolution with single-cell sequencing
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro
Fig. 2. Human liver tissue seed grafts expand after host liver injury.
Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge by Chris A. R. Baker, Louise Swainson, Din L.
Fig. 5. High burdens of AA signature mutations and predicted immunogenicity in Taiwan HCCs. High burdens of AA signature mutations and predicted immunogenicity.
Making Prospective Registration of Observational Research a Reality
Fig. 3. miR overexpression leads to increased cell proliferation as well as altered differentiation and metabolism in cardiomyocytes. miR
Fig. 5 Clustering of the distal gut microbiome, the C
Fig. 1. Forecasting the future.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Fig. 4 Gallium increases P. aeruginosa sensitivity to peroxides.
Fig. 8 Immune correlates of protection.
PD and efficacy of AZD4785 in a KRAS wild-type lung cancer PDX model
Fig. 3 Postnatal assembly of the humanized gut microbiota.
Evaluating the performance of the robotic system through comparison with human trackers. Evaluating the performance of the robotic system through comparison.
Fig. 6. Connectivity and mobility maps for Lesotho.
Fig. 1. Maps of Lesotho, a landlocked country within South Africa.
Fig. 2 Astrocyte-specific AAV2/5 RiboTag.
Presentation transcript:

by Peter Bacchetti, Steven G. Deeks, and Joseph M. McCune Breaking Free of Sample Size Dogma to Perform Innovative Translational Research by Peter Bacchetti, Steven G. Deeks, and Joseph M. McCune Sci Transl Med Volume 3(87):87ps24-87ps24 June 15, 2011 Copyright © 2011, American Association for the Advancement of Science

Fig. 1. How sample size influences the scientific or practical value that a study can be expected to produce, under three different scenarios. How sample size influences the scientific or practical value that a study can be expected to produce, under three different scenarios. Numeric labels on the axes are absent because specific values will differ for different studies, but the qualitative relationship illustrated applies to all studies of new ideas. When the idea is a fundamental breakthrough, this will usually be apparent from a relatively small study. A much larger sample size does not produce much additional value. Similarly, when the idea is completely off-target, this will usually be apparent from a relatively small study. In intermediate cases, larger sample sizes might add value. However, increasing sample size still produces diminishing marginal returns. Peter Bacchetti et al., Sci Transl Med 2011;3:87ps24 Copyright © 2011, American Association for the Advancement of Science